Liquid biopsy is a method of non-invasive monitoring method of tumor’s genome changes. Using a simple blood sample you can determine the evolution of the tumor, the way resistance mechanisms are developing, the dynamics of the disease’s progression and also change the treatment’s tactic just in time.

The idea of the liquid biopsy is based on finding and analyzing cell-free circulating DNA and RNA (ctDNA, ctRNA), microRNA and exosomes, which are produded by the tumor cells.

Liguid biopsy depending on the tumor’s progression stage lets you determine the information like the stage of the disease and the heterogeneity of the tumor, the sensitivity and the resistance of the tumor to various therapy, the tumor’s response to the therapy and the way the resistance may develop, and also the underlying mechanisms of its development